動物用神経変性疾患診断の市場規模、シェア、動向分析レポート：動物タイプ別、診断検査別、製品別、適応症別、最終用途別、地域別、セグメント予測、2025～2030年

動物用神経変性疾患診断市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の動物用神経変性疾患診断の市場規模は2030年までに5億9,610万米ドルに達すると予測され、2025～2030年までのCAGRは8.69％で成長すると予測されています。

市場成長の要因はいくつかあります。

世界のペット飼育数の増加により、神経変性診断や治療を含む高度な獣医療に対する需要が高まっています。また、犬の認知機能障害のような加齢に伴う神経疾患に対する飼い主の意識の高まりが、早期診断と介入を促進しています。さらに、動物用画像診断とバイオマーカー診断の進歩により、神経変性疾患の正確かつ非侵襲的な検出が可能になっています。新規治療薬や神経保護薬の入手可能性に加えて、獣医神経科学における研究開発活動の活発化が治療の選択肢を広げています。動物を家族の一員として扱うというペットの人間化の動向は、専門的ヘルスケアサービスへの支出をさらに促しています。動物の健康インフラとサービスを改善するための政府および民間の支援イニシアティブも、市場の成長を後押ししています。

獣医師数の増加は、動物の神経疾患の専門的ケアと早期診断へのアクセスを拡大することで、市場に大きく貢献しています。例えば、AVMAによると、獣医師の数は2023年の12万7,131人から2024年には13万415人に増加しています。この分野に参入する獣医師、特に神経学の訓練を受けた獣医師が増えるにつれて、神経画像診断、バイオマーカー検査、オーダーメイドの治療計画といった高度なサービスの利用可能性が高まります。これはケアの質を向上させるだけでなく、発作、行動の変化、運動能力の問題などの症状に対して早期に医療措置を求めるペットの飼い主の自信を高めます。さらに、獣医の労働力が増加することで、最先端技術や治療法の導入が容易になり、サービス能力やアウトリーチの強化を通じて市場の拡大が加速します。

さらに、主要企業による戦略的イニシアチブは、技術革新の促進、市場範囲の拡大、診断能力の向上により、市場の成長を大きく後押ししています。例えば、2024年10月、獣医用画像機器およびソリューションの専門企業であるWOORIEN Co., Ltdは、「MyVet CT Plus」を発売しました。小型のトカゲから大型のレトリーバーまで、幅広いサイズの動物に対応するように設計されたMyVet CT Plusは、画質が向上し、大幅に高速化された画像撮影を提供します。前モデルと比較して、撮影時間を少なくとも45％短縮し、最大80％の短縮が可能です。

動物用神経変性疾患診断市場レポートのハイライト

• 消耗品、試薬、キットセグメントが2024年の市場収益シェアで最大を占めました。これらの製品は、獣医師が高度な分子生物学的・生化学的検査を実施するのをサポートするもので、臨床症状のみでは特定が困難な複雑な神経変性疾患の診断に不可欠です。
• 2024年には、コンパニオンセグメントが最大の市場収益シェアを占めました。また、このセグメントは予測期間中に最も速いCAGRで成長すると予測されています。
• 2024年の市場収益シェアは画像診断セグメントが最も大きく、動物の神経疾患の早期かつ正確な診断に重要な役割を果たすことがその要因となっています。
• 認知機能障害セグメントは、コンパニオンアニマルにおけるその高い有病率と、発生を防ぐための迅速かつ正確な検出の重要な必要性により、2024年に40.35%の最大の収益シェアを占めて市場をリードしました。
• 動物病院・診療所は、動物が最初の評価と診断を受ける主要な場所であるため、世界市場で支配的な地位を占めています。
• 北米は2024年に38.25％の最大の収益シェアで市場を独占し、アジア太平洋地域は予測期間中に最も速いCAGRで経験すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 動物用神経変性疾患診断市場の変動動向と展望

• 市場系統の展望
  • 親市場
  • 補助市場
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• 動物用神経変性疾患診断市場の分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • 規制の枠組み
  • 価格分析
  • ペット飼育者の人口統計
  • 主要国別、主要タイプ別の動物推定個体数（2024年）

第4章 動物用神経変性疾患診断市場：動物タイプ別の推定・動向分析

• セグメントダッシュボード
• 動物用神経変性疾患診断市場：動物タイプ別の変動分析
• 動物用神経変性疾患診断市場規模と動向分析（動物タイプ別、2018～2030年）
• 家畜
  • 羊
  • 牛
  • その他
• コンパニオンアニマル
  • 犬
  • 猫
  • 馬
  • その他

第5章 動物用神経変性疾患診断市場：診断検査別の推定・動向分析

• セグメントダッシュボード
• 動物用神経変性疾患診断市場：診断検査別の変動分析
• 動物用神経変性疾患診断市場規模と動向分析（診断検査別、2018～2030年）
• 画像診断
  • MRI（磁気共鳴画像）
  • CT（コンピュータ断層撮影）
  • その他
• バイオマーカー診断検査
  • 脳脊髄液（CSF）バイオマーカー
  • 血液ベースバイオマーカー
  • その他
• その他

第6章 動物用神経変性疾患診断市場：製品別の推定・動向分析

• セグメントダッシュボード
• 動物用神経変性疾患診断市場：製品別の変動分析
• 動物用神経変性疾患診断市場規模と動向分析（製品別、2018～2030年）
  • 消耗品、試薬、キット
  • 機器・器具

第7章 動物用神経変性疾患診断市場：適応症別の推定・動向分析

• セグメントダッシュボード
• 動物用神経変性疾患診断市場：適応症別の変動分析
• 動物用神経変性疾患診断市場規模と動向分析（適応症別、2018～2030年）
  • 認知機能障害
  • 小脳アビオトロフィー
  • 海綿状脳症
  • その他

第8章 動物用神経変性疾患診断市場：最終用途別の推定・動向分析

• セグメントダッシュボード
• 動物用神経変性疾患診断市場：最終用途別の変動分析
• 動物用神経変性疾患診断市場規模と動向分析（最終用途別、2018～2030年）
  • 動物病院・診療所
  • 獣医診断研究所
  • その他

第9章 動物用神経変性疾患診断市場：地域別の推定・動向分析

• 地域別のダッシュボード
• 動物用神経変性疾患診断市場シェア（地域別、2024年および2030年）
• 地域展望
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 市場参入企業の分類
• 企業の市況分析/ヒープマップ分析
• 企業プロファイル
  • Zoetis Services LLC.
  • Virbac.
  • Life Diagnostics.
  • ACUVET BIOTECH
  • Merck &Co., Inc.
  • IDEXX Laboratories, Inc.
  • MI：RNA Diagnostics Ltd.
  • Mercodia AB
  • Antech Diagnostics, Inc.
  • Avacta Animal Health Limited参加者概要
• 戦略マッピング
  • 合併と買収
  • パートナーシップとコラボレーション
  • 製品発売
  • その他
• その他の主要人物一覧

List of Tables

• Table 1 List of secondary sources
• Table 2 Veterinary Neurodegenerative Disease Diagnostics Market, by region, 2018 - 2030 (USD Million)
• Table 3 Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 4 Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 5 Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 6 Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 7 Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 8 North America Veterinary Neurodegenerative Disease Diagnostics Market, by country, 2018 - 2030 (USD Million)
• Table 9 North America Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 10 North America Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 11 North America Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 12 North America Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 13 North America Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 14 U.S Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 15 U.S Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 16 U.S Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 17 U.S Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 18 U.S Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 19 Canada Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 20 Canada Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 21 Canada Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 22 Canada Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 23 Canada Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 24 Mexico Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 25 Mexico Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 26 Mexico Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 27 Mexico Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 28 Mexico Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 29 Europe Veterinary Neurodegenerative Disease Diagnostics Market, by country, 2018 - 2030 (USD Million)
• Table 30 Europe Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 31 Europe Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 32 Europe Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 33 Europe Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 34 Europe Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 35 Germany Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 36 Germany Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 37 Germany Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 38 Germany Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 39 Germany Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 40 UK Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 41 UK Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 42 UK Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 43 UK Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 44 UK Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 45 France Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 46 France Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 47 France Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 48 France Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 49 France Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 50 Italy Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 51 Italy Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 52 Italy Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 53 Italy Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 54 Italy Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 55 Spain Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 56 Spain Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 57 Spain Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 58 Spain Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 59 Spain Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 60 Denmark Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 61 Denmark Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 62 Denmark Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 63 Denmark Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 64 Denmark Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 65 Sweden Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 66 Sweden Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 67 Sweden Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 68 Sweden Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 69 Sweden Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 70 Norway Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 71 Norway Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 72 Norway Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 73 Norway Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 74 Norway Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 75 Asia Pacific Veterinary Neurodegenerative Disease Diagnostics Market, by country, 2018 - 2030 (USD Million)
• Table 76 Asia Pacific Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 77 Asia Pacific Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 78 Asia Pacific Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 79 Asia Pacific Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 80 Asia Pacific Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 81 China Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 82 China Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 83 China Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 84 China Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 85 China Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 86 Japan Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 87 Japan Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 88 Japan Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 89 Japan Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 90 Japan Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 91 India Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 92 India Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 93 India Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 94 India Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 95 India Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 96 South Korea Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 97 South Korea Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 98 South Korea Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 99 South Korea Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 100 South Korea Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 101 Australia Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 102 Australia Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 103 Australia Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 104 Australia Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 105 Australia Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 106 Thailand Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 107 Thailand Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 108 Thailand Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 109 Thailand Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 110 Thailand Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 111 Latin America Veterinary Neurodegenerative Disease Diagnostics Market, by country, 2018 - 2030 (USD Million)
• Table 112 Latin America Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 113 Latin America Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 114 Latin America Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 115 Latin America Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 116 Latin America Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 117 Brazil Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 118 Brazil Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 119 Brazil Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 120 Brazil Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 121 Brazil Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 122 Argentina Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 123 Argentina Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 124 Argentina Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 125 Argentina Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 126 Argentina Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 127 MEA Veterinary Neurodegenerative Disease Diagnostics Market, by country, 2018 - 2030 (USD Million)
• Table 128 MEA Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 129 MEA Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 130 MEA Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 131 MEA Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 132 MEA Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 133 South Africa Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 134 South Africa Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 135 South Africa Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 136 South Africa Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 137 South Africa Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 138 Saudi Arabia Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 139 Saudi Arabia Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 140 Saudi Arabia Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 141 Saudi Arabia Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 142 Saudi Arabia Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 143 UAE Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 144 UAE Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 145 UAE Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 146 UAE Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 147 UAE Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 148 Kuwait Veterinary Neurodegenerative Disease Diagnostics Market, by Animal type, 2018 - 2030 (USD Million)
• Table 149 Kuwait Veterinary Neurodegenerative Disease Diagnostics Market, by Indication, 2018 - 2030 (USD Million)
• Table 150 Kuwait Veterinary Neurodegenerative Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 151 Kuwait Veterinary Neurodegenerative Disease Diagnostics Market, by Diagnostic Tests, 2018 - 2030 (USD Million)
• Table 152 Kuwait Veterinary Neurodegenerative Disease Diagnostics Market, by End use, 2018 - 2030 (USD Million)
• Table 153 Company Overview
• Table 154 Product Benchmarking
• Table 155 Financial Performance
• Table 156 Strategic Initiatives

List of Figures

• Fig. 1 Market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modelling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Veterinary Neurodegenerative Disease Diagnostics Market revenue, 2018 - 2030 (USD Million)
• Fig. 10 Veterinary Neurodegenerative Disease Diagnostics Market snapshot
• Fig. 11 Veterinary Neurodegenerative Disease Diagnostics Market driver impact
• Fig. 12 Veterinary Neurodegenerative Disease Diagnostics Market restraint impact
• Fig. 13 Veterinary Neurodegenerative Disease Diagnostics animal type key takeaways (USD Million)
• Fig. 14 Veterinary Neurodegenerative Disease Diagnostics Market: animal Type movement analysis
• Fig. 15 Companion market, 2018 - 2030 (USD Million)
• Fig. 16 canine market, 2018 - 2030 (USD Million)
• Fig. 17 Feline market, 2018 - 2030 (USD Million)
• Fig. 18 Equine market, 2018 - 2030 (USD Million)
• Fig. 19 Others market, 2018 - 2030 (USD Million)
• Fig. 20 Livestock market, 2018 - 2030 (USD Million)
• Fig. 21 Sheep market, 2018 - 2030 (USD Million)
• Fig. 22 Cattle market, 2018 - 2030 (USD Million)
• Fig. 23 others market, 2018 - 2030 (USD Million)
• Fig. 24 Veterinary Neurodegenerative Disease Diagnostics Market Product key takeaways (USD Million)
• Fig. 25 Veterinary Neurodegenerative Disease Diagnostics Market: product movement analysis
• Fig. 26 Consumables, Reagents & Kits market, 2018 - 2030 (USD Million)
• Fig. 27 Equipment & Instruments market, 2018 - 2030 (USD Million)
• Fig. 28 Veterinary Neurodegenerative Disease Diagnostics Market Diagnostic Tests key takeaways (USD Million)
• Fig. 29 Veterinary Neurodegenerative Disease Diagnostics Market: Diagnostic Tests movement analysis
• Fig. 30 Imaging market, 2018 - 2030 (USD Million)
• Fig. 31 MRI (Magnetic Resonance Imaging) market, 2018 - 2030 (USD Million)
• Fig. 32 CT (Computed Tomography) market, 2018 - 2030 (USD Million)
• Fig. 33 Others market, 2018 - 2030 (USD Million)
• Fig. 34 Biomarker Diagnostic Tests market, 2018 - 2030 (USD Million)
• Fig. 35 CSF (Cerebrospinal Fluid) biomarkers market, 2018 - 2030 (USD Million)
• Fig. 36 Blood-based biomarkers market, 2018 - 2030 (USD Million)
• Fig. 37 Others market, 2018 - 2030 (USD Million)
• Fig. 38 Others market, 2018 - 2030 (USD Million)
• Fig. 39 Veterinary Neurodegenerative Disease Diagnostics Market Indication key takeaways (USD Million)
• Fig. 40 Veterinary Neurodegenerative Disease Diagnostics Market: Indication movement analysis
• Fig. 41 Cognitive Dysfunction market, 2018 - 2030 (USD Million)
• Fig. 42 Cerebellar Abiotrophy Flow Assays market, 2018 - 2030 (USD Million)
• Fig. 43 Spongiform Encephalopathies market, 2018 - 2030 (USD Million)
• Fig. 44 Others market, 2018 - 2030 (USD Million)
• Fig. 45 Veterinary Neurodegenerative Disease Diagnostics Market by End Use key takeaways (USD Million)
• Fig. 46 Veterinary Neurodegenerative Disease Diagnostics Market: by End Use movement analysis
• Fig. 47 Veterinary Diagnostic Laboratories market, 2018 - 2030 (USD Million)
• Fig. 48 Veterinary Hospitals and Clinics market, 2018 - 2030 (USD Million)
• Fig. 49 Others market, 2018 - 2030 (USD Million)
• Fig. 50 Regional market place: Key takeaways
• Fig. 51 Regional outlook, 2024 & 2030
• Fig. 52 North America Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 53 U.S. Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 54 Canada Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 55 Mexico Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 56 Europe Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 57 UK Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 58 Germany Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 59 France Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 60 Italy Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 61 Spain Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 62 Denmark Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 63 Sweden Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 64 Norway Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 65 Asia Pacific Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 66 Japan Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 67 China Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 68 India Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 69 Australia Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 70 South Korea Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 71 Thailand Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 72 Latin America Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 73 Brazil Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 74 Argentina Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 75 MEA Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 76 South Africa Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 77 Saudi Arabia Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 78 UAE Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 79 Kuwait Veterinary Neurodegenerative Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 80 Market participant categorization

Veterinary Neurodegenerative Disease Diagnostics Market Growth & Trends:

The global veterinary neurodegenerative disease diagnostics market size is anticipated to reach USD 596.1 million by 2030 and is projected to grow at a CAGR of 8.69% from 2025 to 2030, according to a new report by Grand View Research, Inc. Several factors are responsible for the market growth.

Firstly, the rising pet ownership globally has increased demand for advanced veterinary care, including neurodegenerative diagnostics and treatments. Secondly, the growing awareness among pet owners about age-related neurological conditions, such as canine cognitive dysfunction, is driving early diagnosis and intervention. Thirdly, advancements in veterinary imaging and biomarker diagnostics are enabling accurate and non-invasive detection of neurodegenerative diseases. In addition, increased research and development activities in veterinary neuroscience, along with the availability of novel therapeutics and neuroprotective drugs, are expanding treatment options. The trend of pet humanization, where animals are treated as family members, further encourages spending on specialized healthcare services. Lastly, supportive government and private initiatives to improve animal health infrastructure and services are also boosting market growth.

The increasing number of veterinarians contributes significantly to the market by expanding access to specialized care and early diagnosis of neurological disorders in animals. For instance, according to AVMA, the number of veterinarians increased to 130,415 in 2024 from 127,131 in 2023. As more veterinary professionals enter the field, especially those trained in neurology, the availability of advanced services such as neuroimaging, biomarker testing, and tailored treatment plans rises. This not only improves the quality of care but also boosts pet owners' confidence in seeking early medical attention for symptoms like seizures, behavioral changes, or mobility issues. Moreover, a larger veterinary workforce facilitates the adoption of cutting-edge technologies and therapies, thereby accelerating market expansion through enhanced service capacity and outreach.

Moreover, strategic initiatives by key players are significantly driving the market growth by fostering innovation, expanding market reach, and improving diagnostic capabilities. For instance, in October 2024, WOORIEN Co., Ltd, a specialist in veterinary imaging equipment and solutions, launched 'MyVet CT Plus.' Designed to accommodate a wide range of animal sizes from small lizards to large retrievers, MyVet CT Plus offers significantly faster imaging with improved quality. Compared to its predecessor, it reduces acquisition time by at least 45%, with potential reductions of up to 80%.

Veterinary Neurodegenerative Disease Diagnostics Market Report Highlights:

• The consumables, reagents, and kits segment accounted for the largest market revenue share in 2024. These products support veterinarians in conducting advanced molecular and biochemical tests, which are essential for diagnosing complex neurodegenerative diseases that are challenging to identify based solely on clinical symptoms.
• The companion segment dominated accounted for the largest market revenue share in 2024. This segment is also anticipated to grow at the fastest CAGR over the forecast period.
• The imaging segment accounted for the largest market revenue share in 2024, driven by its vital role in the early and accurate diagnosis of neurological disorders in animals.
• The cognitive dysfunction segment led the market with the largest revenue share of 40.35% in 2024, driven by its high prevalence in companion animals and the critical need for rapid and accurate detection to prevent outbreaks.
• Veterinary hospitals and clinics hold a dominant position in the global market, as they are the primary locations where animals receive their initial assessment and diagnosis.
• North America dominated the market with the largest revenue share of 38.25% in 2024, while the Asia Pacific region is projected to experience at the fastest CAGR during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. Global Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Veterinary Neurodegenerative Disease Diagnostics Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of neurodegenerative diseases in companion animals
    • 3.2.1.2. Rising medicalization rate
    • 3.2.1.3. Increasing pet health expenditure
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of standardized regulations
    • 3.2.2.2. Lack of awareness in developing economies
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Veterinary Neurodegenerative Disease Diagnostics Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
  • 3.3.3. Regulatory Framework
  • 3.3.4. Pricing Analysis
  • 3.3.5. Pet ownership Demographics
  • 3.3.6. Estimated Animal Population by key countries, key species, 2024

Chapter 4. Veterinary Neurodegenerative Disease Diagnostics Market: Animal Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Veterinary Neurodegenerative Disease Diagnostics Market: Animal type Movement Analysis
• 4.3. Veterinary Neurodegenerative Disease Diagnostics Market Size & Trend Analysis, by animal type, 2018 to 2030 (USD Million)
• 4.4. Livestock
  • 4.4.1. Livestock Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Sheep
    • 4.4.2.1. Sheep Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Cattle
    • 4.4.3.1. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Others
    • 4.4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Companion
  • 4.5.1. Companion Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Canine
    • 4.5.2.1. Canine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Feline
    • 4.5.3.1. Feline Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.4. Equine
    • 4.5.4.1. Equine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.5. Others
    • 4.5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Neurodegenerative Disease Diagnostics Market: Diagnostic Tests Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Veterinary Neurodegenerative Disease Diagnostics Market: Diagnostic Tests Movement Analysis
• 5.3. Veterinary Neurodegenerative Disease Diagnostics Market Size & Trend Analysis, by Diagnostic Tests, 2018 to 2030 (USD Million)
• 5.4. Imaging
  • 5.4.1. Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. MRI (Magnetic Resonance Imaging)
    • 5.4.2.1. MRI (Magnetic Resonance Imaging) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.3. CT (Computed Tomography)
    • 5.4.3.1. CT (Computed Tomography) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.4. Others
    • 5.4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Biomarker Diagnostic Tests
  • 5.5.1. Biomarker Diagnostic Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.2. CSF (Cerebrospinal Fluid) biomarkers
    • 5.5.2.1. CSF (Cerebrospinal Fluid) biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.3. Blood-based biomarkers
    • 5.5.3.1. Blood-based biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.4. Others
    • 5.5.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Neurodegenerative Disease Diagnostics Market: By Product Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Veterinary Neurodegenerative Disease Diagnostics Market: By Product Movement Analysis
• 6.3. Veterinary Neurodegenerative Disease Diagnostics Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
  • 6.3.1. Consumables, Reagents & Kits
    • 6.3.1.1. Consumables, Reagents & Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. Equipment & Instruments
    • 6.3.2.1. Equipment & Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Neurodegenerative Disease Diagnostics Market: By Indication Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Veterinary Neurodegenerative Disease Diagnostics Market: By Indication Movement Analysis
• 7.3. Veterinary Neurodegenerative Disease Diagnostics Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 7.3.1. Cognitive Dysfunction
    • 7.3.1.1. Cognitive Dysfunction Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. Cerebellar Abiotrophy
    • 7.3.2.1. Cerebellar Abiotrophy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Spongiform Encephalopathies
    • 7.3.3.1. Spongiform Encephalopathies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.4. Others
    • 7.3.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Veterinary Neurodegenerative Disease Diagnostics Market: By End Use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Veterinary Neurodegenerative Disease Diagnostics Market: By End Use Movement Analysis
• 8.3. Veterinary Neurodegenerative Disease Diagnostics Market Size & Trend Analysis, by End use, 2018 to 2030 (USD Million)
  • 8.3.1. Veterinary Hospitals and Clinics
    • 8.3.1.1. Veterinary Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. Veterinary Diagnostic Laboratories
    • 8.3.2.1. Veterinary Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.3. Others
    • 8.3.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Veterinary Neurodegenerative Disease Diagnostics Market: Regional Estimates & Trend Analysis

• 9.1. Regional Dashboard
• 9.2. Veterinary Neurodegenerative Disease Diagnostics Market Share, By Region, 2024 & 2030, USD Million
• 9.3. Regional Outlook
• 9.4. North America
  • 9.4.1. North America Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.2. U.S.
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. U.S. Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.3. Canada
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Canada Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.4. Mexico
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Mexico Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.5. Europe
  • 9.5.1. Europe Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.2. UK
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. UK Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.3. Germany
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Germany Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.4. France
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. France Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.5. Italy
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Italy Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.6. Spain
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Spain Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.7. Denmark
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Denmark Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.8. Sweden
    • 9.5.8.1. Key Country Dynamics
    • 9.5.8.2. Sweden Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.9. Norway
    • 9.5.9.1. Key Country Dynamics
    • 9.5.9.2. Norway Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.6. Asia Pacific
  • 9.6.1. Asia Pacific Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.2. Japan
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Japan Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.3. China
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. China Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.4. India
    • 9.6.4.1. Key Country Dynamics
    • 9.6.4.2. India Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.5. Australia
    • 9.6.5.1. Key Country Dynamics
    • 9.6.5.2. Australia Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.6. South Korea
    • 9.6.6.1. Key Country Dynamics
    • 9.6.6.2. South Korea Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.7. Thailand
    • 9.6.7.1. Key Country Dynamics
    • 9.6.7.2. Thailand Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.7. Latin America
  • 9.7.1. Latin America Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.2. Brazil
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Brazil Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.3. Argentina
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Argentina Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.8. Middle East & Africa
  • 9.8.1. Middle East & Africa Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.2. South Africa
    • 9.8.2.1. Key Country Dynamics
    • 9.8.2.2. South Africa Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.3. Saudi Arabia
    • 9.8.3.1. Key Country Dynamics
    • 9.8.3.2. Saudi Arabia Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.4. UAE
    • 9.8.4.1. Key Country Dynamics
    • 9.8.4.2. UAE Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.5. Kuwait
    • 9.8.5.1. Key Country Dynamics
    • 9.8.5.2. Kuwait Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Market Participant Categorization
• 10.2. Company Market Position Analysis/ Heap Map Analysis
• 10.3. Company Profiles
  • 10.3.1. Zoetis Services LLC.
    • 10.3.1.1. Participant's Overview
    • 10.3.1.2. Financial Performance
    • 10.3.1.3. Product Benchmarking
    • 10.3.1.4. Strategic Initiatives
  • 10.3.2. Virbac.
    • 10.3.2.1. Participant's Overview
    • 10.3.2.2. Financial Performance
    • 10.3.2.3. Product Benchmarking
    • 10.3.2.4. Strategic Initiatives
  • 10.3.3. Life Diagnostics.
    • 10.3.3.1. Participant's Overview
    • 10.3.3.2. Financial Performance
    • 10.3.3.3. Product Benchmarking
    • 10.3.3.4. Strategic Initiatives
  • 10.3.4. ACUVET BIOTECH
    • 10.3.4.1. Participant's Overview
    • 10.3.4.2. Financial Performance
    • 10.3.4.3. Product Benchmarking
    • 10.3.4.4. Strategic Initiatives
  • 10.3.5. Merck & Co., Inc.
    • 10.3.5.1. Participant's Overview
    • 10.3.5.2. Financial Performance
    • 10.3.5.3. Product Benchmarking
    • 10.3.5.4. Strategic Initiatives
  • 10.3.6. IDEXX Laboratories, Inc.
    • 10.3.6.1. Participant's Overview
    • 10.3.6.2. Financial Performance
    • 10.3.6.3. Product Benchmarking
    • 10.3.6.4. Strategic Initiatives
  • 10.3.7. MI: RNA Diagnostics Ltd.
    • 10.3.7.1. Participant's Overview
    • 10.3.7.2. Financial Performance
    • 10.3.7.3. Product Benchmarking
    • 10.3.7.4. Strategic Initiatives
  • 10.3.8. Mercodia AB
    • 10.3.8.1. Participant's Overview
    • 10.3.8.2. Financial Performance
    • 10.3.8.3. Product Benchmarking
    • 10.3.8.4. Strategic Initiatives
  • 10.3.9. Antech Diagnostics, Inc.
    • 10.3.9.1. Participant's Overview
    • 10.3.9.2. Financial Performance
    • 10.3.9.3. Product Benchmarking
    • 10.3.9.4. Strategic Initiatives
  • 10.3.10. Avacta Animal Health Limited Participant's Overview
    • 10.3.10.1. Participant's Overview
    • 10.3.10.2. Financial Performance
    • 10.3.10.3. Product Benchmarking
    • 10.3.10.4. Strategic Initiatives
• 10.4. Strategy Mapping
  • 10.4.1. Mergers & Acquisitions
  • 10.4.2. Partnerships & Collaborations
  • 10.4.3. Product launch
  • 10.4.4. Others
• 10.5. List of other key players